Altraz 1 mg

Description

Altraz 1mg exists as a prescribed medication that comprises the active pharmaceutical element Anastrozole while being classified under anti-cancer medications. As a product from Cipla Ltd, Altraz 1mg exists as a pill form that specifically treats breast cancer in postmenopausal females. The irregular cell development within mammary glands becomes breast cancer when these cells produce lumps, which can disseminate throughout the body.

Mechanism of Action

The medicinal impact of Altraz 1mg depends on body estrogen level reduction. The mechanism functions by obstructing aromatase, the natural enzyme liable for restoring male hormones into female hormones. Hormonal treatment with Altraz 1mg remains necessary for breast cancer therapy because diminishing estrogen stops tumor growth in hormone receptor-positive patients.

Key Features

Active Ingredient: Anastrozole 1mg

Dosage Form: Tablet

Indication: Hormone receptor-positive breast cancer in postmenopausal women

Therapeutic Benefits

• The amount of estrogen decreases because this hormone stops the development of tumors that need estrogen for survival. 
• The medication functions as an adjuvant tool for reducing or eliminating cancer lesions after surgical procedures or radiation therapy sessions.
• Assists in metastatic breast cancer treatment and enhances the general survival rate.

Potential Side Effects

The common side effects that are likely to be experienced while using Altraz 1mg are as follows:

• Hot flashes
• Joint pain
• Fatigue
• Nausea
• Osteoporosis risk

Conclusion

Altraz 1mg is an essential pill that is required for women who are suffering from breast cancer after menopause. Long-term treatment success improves because this medication minimizes tumor formation while reducing estrogen production levels. Every user should get medical advice regarding the potential advantages and side effects before starting this medication. Regular monitoring alongside healthy habits makes a substantial contribution to the achievement of treatment goals.